Showing results (551-560 of 700) with videos related to

Sort By:
Pageof 70
Cell Reports|September 24, 2013
Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanomaJessie Villanueva, Jeffrey R Infante, Clemens Krepler, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2016
International cancer seminars: a focus on kidney cancerG Scelo, J N Hofmann, R E Banks, et al.
Andrology|January 5, 2026
The Testicular Cancer Consortium (TECAC): Filling Knowledge Gaps in the Genetic Etiology of Testicular Germ Cell TumorsPeter A Kanetsky, Kristian Almstrup, Svetlana Cherlin, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
JAMA Oncology|January 25, 2019
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell TumorsSaud H AlDubayan, Louise C Pyle, Marija Gamulin, et al.
Science Immunology|March 6, 2026
Modulating AP-1 enables CAR T cells to establish an intratumoral stemlike reservoir and overcomes resistance to PD-1 blockadeAndrew J Snyder, Sarah M Garrison, Mitchell G Kluesner, et al.
Cell Reports|November 16, 2017
Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell LinesBradley Garman, Ioannis N Anastopoulos, Clemens Krepler, et al.
Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.
Pageof 70